Company Profile
Gilead Sciences Stock Price, News & Analysis
- Ticker:
- GILD
- Exchange:
- NASDAQ
- Sector:
- Biotechnology
- Location:
- United States
Why the stock is moving
GILD is trading with a steady catalyst profile while investors wait for the next headline that changes the story.
Company overview
Business overview
Gilead Sciences is a large-cap biopharmaceutical company with a commercial base anchored by antivirals and a growing set of oncology and inflammation programs. Investors track the balance between cash flow strength, launch execution, and pipeline replacement.
Geographic Base and Sector Classification
Headquartered in Foster City, California and listed on NASDAQ, Gilead Sciences is followed within the large-cap biotech universe for its mix of antiviral history, oncology exposure, and commercial scale.
Business Model Characteristics
Gilead combines a durable commercial base with ongoing pipeline renewal. The market usually focuses on launch cadence, margin discipline, and whether the company can continue replacing older revenue with new product growth.
Position Within the Biotechnology Landscape
Compared with smaller biotech peers, Gilead trades as a mature commercial biotech name, where cash flow, pipeline conversion, and launch execution matter more than one single data event.
Future catalysts
Gilead’s biggest near-term catalyst is lenacapavir, especially prevention and filing progress, alongside Trodelvy and the oncology franchise. The next checkpoint matters because it tells investors whether the program is still moving on schedule or whether the timeline needs to be reset. A clean outcome also makes it easier to think about the next regulatory or label step instead of just the current filing.
Recent news
The five most recent feed items are shown below in reverse chronological order.
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What does Gilead Sciences do?
Gilead Sciences is a large-cap biopharmaceutical company with a commercial base anchored by antivirals and a growing set of oncology and inflammation programs. Investors track the balance between cash flow strength, launch execution, and pipeline replacement.
Where is Gilead Sciences based and where is the stock listed?
Gilead Sciences is listed on NASDAQ, Headquartered in Foster City, California and listed on NASDAQ, Gilead Sciences is followed within the large-cap biotech universe for its mix of antiviral history, oncology exposure, and commercial scale., followed in 抗病毒技术平台,生物技术,RNAi,CAR-T,基因治疗.
On which exchange is GILD stock listed?
Gilead Sciences (GILD) is associated with NASDAQ, United States, Biotechnology.
What is lenacapavir?
Gilead’s biggest near-term catalyst is lenacapavir, especially prevention and filing progress, alongside Trodelvy and the oncology franchise.
Which conditions is Gilead Sciences targeting with lenacapavir?
Gilead Sciences is associated with oncology, inflammatory disease based on its company overview and current catalyst commentary.
How does Gilead Sciences describe recent progress with lenacapavir?
Gilead’s biggest near-term catalyst is lenacapavir, especially prevention and filing progress, alongside Trodelvy and the oncology franchise.
What is Gilead?
Gilead Sciences is a large-cap biopharmaceutical company with a commercial base anchored by antivirals and a growing set of oncology and inflammation programs.
What should investors watch for with Gilead?
Gilead’s biggest near-term catalyst is lenacapavir, especially prevention and filing progress, alongside Trodelvy and the oncology franchise.
What is Sciences?
Gilead Sciences is a large-cap biopharmaceutical company with a commercial base anchored by antivirals and a growing set of oncology and inflammation programs.